Results 1 to 10 of about 1,359,149 (381)

Treatment of corneoscleral mixed hemangioma by intrastromal lenticule transplantation in a case of xeroderma pigmentosum: a case report [PDF]

BMC Ophthalmology
Background Xeroderma pigmentosum (XP) is a rare autosomal recessive skin disease. The ocular manifestations in XP patients usually include severe photophobia, conjunctivitis, corneal opacification, ocular surface squamous neoplasia (OSSN) which often ...
Yingwei Wang, Li Cai, Hua Feng, Xiaofei Wu, Hongmin Ke, Jerry Ma, Wanmei Tang, Kunling Chen, Qiong Wang   +8 more
doaj   +2 more sources

Living-donor liver transplantation for giant hepatic hemangioma with diffuse hemangiomatosis in an adult: a case report [PDF]

Clinical and Molecular Hepatology, 2018
Hepatic hemangioma represents the most common benign primary hepatic neoplasm. Although most such tumors are small and asymptomatic, giant hepatic hemangioma is frequently symptomatic, and requires intervention.
Ju Hyun Lee, Chang Jin Yoon, Young Hoon Kim, Ho-Seong Han, Jai Young Cho, Haeryoung Kim, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong   +8 more
doaj   +2 more sources

Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia

Haematologica, 2016
Acute myeloid leukemia is a clonal neoplasm derived from myeloid progenitor cells with a varying outcome. The initial goal of treatment is the achievement of complete remission, defined for over 40 years by morphology.
Gert J. Ossenkoppele, Jeroen J.W.M. Janssen, Arjan A. van de Loosdrecht   +2 more
doaj   +2 more sources

Allogeneic Hematopoietic Cell Transplantation for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Bone Marrow Transplantation, 2021
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an aggressive hematological malignancy; however, some patients achieve durable remission with allogeneic hematopoietic cell transplantation (allo-HCT).
Q. Bashir, D. Milton, U. Popat, P. Kebriaei, C. Hosing, I. Khouri, K. Rezvani, Y. Nieto, B. Oran, S. Srour, N. Saini, A. Olson, Saira S. Ahmed, G. Al-Atrash, G. Rondon, M. Konopleva, R. Champlin, E. Shpall, M. Qazilbash, N. Pemmaraju   +19 more
semanticscholar   +1 more source

Extramedullary relapse of Immunoglobulin A-kappa myeloma manifesting as plasmacytoma of the pleura without bone marrow involvement and following autologous bone marrow transplant: a case report

Journal of Medical Case Reports, 2023
Background Recurrence of multiple myeloma is among the most challenging issues for patients and treating physicians reported after autologous stem cell transplantation.
Alireza Rezvani, Reza Shahriarirad, Mohammad Javad Fallahi, Ali Zeighami   +3 more
doaj   +1 more source

Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies.

Leukemia, 2023
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that can involve the bone marrow, peripheral blood, skin, lymph nodes, and the central nervous system.
Branko Cuglievan, Jeremy Connors, Jia He, S. Khazal, Sireesha Yedururi, J. Dai, S. Garcés, Andrés E Quesada, Michael Roth, Miriam Garcia, D. McCall, Amber Gibson, D. Ragoonanan, D. Petropoulos, P. Tewari, C. Nunez, K. Mahadeo, S. Tasian, A. Lamble, A. Pawlowska, D. Hammond, A. Maiti, F. Haddad, Jayatsu Senapati, Naval G Daver, N. Gangat, M. Konopleva, S. Meshinchi, N. Pemmaraju   +28 more
semanticscholar   +1 more source

Recurrent facial microcystic adnexal carcinoma and hair transplantation on scar site

Clinical Case Reports, 2023
Key Clinical Message Microcystic adnexal carcinoma (MAC) is a rare kind of cutaneous neoplasm with a very aggressive local infiltration that destructs the affected tissues.
Amir Mohammad Beyzaee, Mohamad Goldust, Anant Patil, Ghasem Rahmatpour Rokni, Bahare Ghoreishi   +4 more
doaj   +1 more source

North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: Position on Standards of Care and Areas of Need.

Blood, 2022
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy with historically poor outcomes and no worldwide consensus treatment approach.
N. Pemmaraju, H. Kantarjian, K. Sweet, E. Wang, J. Senapati, N. Wilson, M. Konopleva, A. Frankel, Vikas Gupta, R. Mesa, M. Ulrickson, E. Gorak, S. Bhatia, T. Budak-Alpdogan, James R. Mason, M. García-Romero, N. López-Santiago, Gabriela Cesarman-Maus, P. Vachhani, Sangmin Lee, V. Bhatt, W. Blum, R. Walter, D. Bixby, I. Gojo, M. Duvic, R. Rampal, M. de Lima, J. Foran, A. Fathi, Aric Hall, Meagan A. Jacoby, J. Lancet, G. Mannis, A. Stein, A. Mims, D. Rizzieri, R. Olin, A. Perl, G. Schiller, P. Shami, R. Stone, S. Strickland, M. Wieduwilt, N. Daver, F. Ravandi, S. Vasu, M. Guzman, G. Roboz, J. Khoury, M. Qazilbash, Phyu P. Aung, Branko Cuglievan, Y. Madanat, M. Kharfan-Dabaja, A. Pawlowska, Justin Taylor, M. Tallman, Prajwal Dhakal, A. Lane   +59 more
semanticscholar   +1 more source

Acute liver failure precipitated by acute Budd‐Chiari syndrome and complete portal vein thrombosis

Clinical Case Reports, 2021
Acute Budd‐Chiari syndrome and complete portal vein thrombosis are important features of myeloproliferative neoplasm that may occur simultaneously, resulting in acute liver failure.
Yuji Suzuki, Akiko Suzuki, Keisuke Kakisaka, Yasuhiro Takikawa   +3 more
doaj   +1 more source

Favorable outcome of a patient with an unclassifiable myelodysplastic syndrome/myeloproliferative neoplasm treated with allogeneic hematopoietic stem cell transplantation

SAGE Open Medical Case Reports, 2021
The entity myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome is characterized by the coexistence of both myeloproliferative and myelodysplastic features in the bone marrow.
Anette Lodvir Hemsing, Bjørn Tore Gjertsen, Signe Spetalen, Lars Helgeland, Håkon Reikvam   +4 more
doaj   +1 more source